Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Trimethyltetradecylammonium is a synthetic quaternary ammonium compound and cationic surfactant. It is primarily used as a germicidal detergent and disinfectant in laboratory and industrial settings. The compound acts by disrupting cell membranes due to its surfactant properties, leading to cell lysis and death of microorganisms. It is not classified as a pharmaceutical drug for therapeutic use in humans but finds application in research, cleaning agents, and possibly as an ingredient in some cosmetic or household products. Its mechanism of action involves interaction with lipid bilayers of microbial membranes, causing increased permeability or complete disruption[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on trimethyltetradecylammonium.